Latest News and Press Releases
Want to stay updated on the latest news?
-
WOBURN, Mass., Jan. 24, 2023 (GLOBE NEWSWIRE) -- Access, the world’s largest privately-held integrated information management services provider, today announced that it has been recognized by Inc....
-
Newark, New Castle, USA, Jan. 19, 2023 (GLOBE NEWSWIRE) -- According to a new market research report titled, “Chronic Pulmonary Aspergillosis Drugs Market by Drug Class (Azole Antifungals,...
-
NEWARK, Del, Jan. 17, 2023 (GLOBE NEWSWIRE) -- The global Vulvovaginal Candidiasis Treatment Market is currently valued at US$ 1035 Million in 2023 and is anticipated to expand at a CAGR of 4.5%....
-
New York, Dec. 30, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Antifungal Drugs Market Research Report by Infection Type, Type, Form, Therapeutic Indications,...
-
New York, Dec. 20, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Vulvovaginal Candidiasis Treatment Market Size, Share & Industry Trends Analysis Report...
-
Seasoned Human Resources Executive Brings 20+ Years of Experience to the Board of Directors EAST RUTHERFORD, NJ, Dec. 19, 2022 (GLOBE NEWSWIRE) -- MamaMancini's Holdings, Inc. (NASDAQ: MMMB), a...
-
BREXAFEMME, an oral, non-azole medication, is the first and only FDA-approved therapy for both the treatment of vulvovaginal candidiasis (VVC) and the reduction in the incidence of recurrent VVC. ...
-
Researchers to study the potential of SCY-247 to fight Candida auris (C.auris), a multidrug-resistant pathogen named as an “urgent threat” by the Centers for Disease Control (CDC) and included in the...
-
BARDA is seeking to support the development of broad-spectrum, oral/IV antifungal drug candidates with novel mechanisms of action that target Candida species, including Candida auris, and Aspergillus...
-
ORLANDO, Fla., Nov. 16, 2022 (GLOBE NEWSWIRE) -- Crawford Thomas Recruiting, the leading nationwide recruiting and staffing firm, announced it has been honored in Inc. Business Media’s inaugural...